The Community for Technology Leaders
RSS Icon
Subscribe
Issue No.07 - July (2010 vol.43)
pp: 35-42
Jatinder R. Palta , University of Florida
Vincent A. Frouhar , University of Florida
Robert A. Zlotecki , University of Florida
ABSTRACT
Cancer-care costs are increasing despite the expansion of disease management and prevention programs. While tremendous scientific progress has led to new tools for diagnosis, treatment, and follow-up, evidence is less complete on the comparative effectiveness of these interventions in actual community practice.
INDEX TERMS
eHealth, Information technology, Pervasive technologies, Atlas Project, Prostate cancer data collection
CITATION
Jatinder R. Palta, Vincent A. Frouhar, Robert A. Zlotecki, "Leveraging Pervasive Technologies to Improve Collection of Prostate Cancer Outcome Data", Computer, vol.43, no. 7, pp. 35-42, July 2010, doi:10.1109/MC.2010.202
REFERENCES
1. Inst. of Medicine, Crossing the Quality Chasm: A New Health System for the 21st Century, National Academies of Science, 2001.
2. Centers for Medicare and Medicaid Services, "National Health Expenditure Data,"6 Jan. 2009.
3. National Cancer Inst., "Costs of Cancer Care," Cancer Trends Progress Report, 2007 update.
4. M.G. Sanda et al., "Quality of Life and Satisfaction with Outcome among prostate cancer survivors," New England J. Medicine, pp. 358:1250-1261.
5. Senate Committee on Finance, "Baucus-Conrad Proposal Can Improve Quality, Lower Costs throughout American Health Care system," press release, Washington, D.C., 1 Aug. 2008.
6. Inst. of Medicine, Knowing What Works in Health Care: A Roadmap for the Nation, Washington, D.C., National Academies Press, 2008.
7. G.R. Wilensky, "Information on Cost-effectiveness: An Essential Product of a National Comparative Effectiveness Program," Annals of Internal Medicine, vol. 148, 2008, pp. 956-61.
8. Inst. of Medicine, "Learning What Works Best: The Nation's Need for Evidence on Comparative Effectiveness in Health Care: IOM Roundtable on Evidence-based Medicine," National Academies of Science, Sept. 2007.
9. T.L. Krupisky et al., "Geographic and Socioeconomic Variation in the Treatment of Prostate Cancer," J. Clinical Oncology, vol. 23, 2005, pp. 7881-7888.
10. T.M. Gill and A.R. Feinstein, "A Critical Appraisal of the Quality of Quality-of-Life Measurements," J. Am Medical Assoc., vol. 272, no. 8, 1994, pp. 619-26.
11. A. Garratt et al., "Quality of Life Measurement: Bibliographic Study of Patient Assessed Health Outcome Measures," British Medical J., vol. 324, 2002, pp. 1351-1417.
12. M.J. Naughton and S.A. Shumaker, "The Case for Domains of Function in Quality of Life Assessment; Quality of Life Research 12," Supplement 1, 2003, pp. 73-80.
13. Patient-reported Outcomes Measurement Information System, NIH Initiative; www.nihpromis.orgdefault.aspx.
14. G. Dubernard et al., "Quality of Life after Sentinel Lymph Node Biopsy in Early Breast Cancer," European J. Surgical Oncology, vol. 30, no. 7, 2004, pp. 728-734.
15. D.L. Mapes et al., "Health-Related Quality of Life as a Predictor of Mortality and Hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS)," Kidney Int'l J., vol. 64, no. 1, 2003, pp. 339-349.
16. J.S. Rumsfeld et al., "Health-related Quality of Life as a Predictor of Mortality Following Coronary Artery Bypass Graft Surgery;" Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery, J. American Medical Assoc., vol. 14, no. 281, 2004, pp. 1298-1303.
17. S. Earlam et al., "Relation between Tumor Size, Quality of Life, and Survival in Patients with Colorectal Liver Metastases," J. Clinical Oncology, vol. 14, no. 1, pp. 171-175.
18. M. Viala et al., "Patient-Reported Outcomes Helped Predict Survival in Multiple Myeloma Using Partial Least Squares Analysis," J. Clinical Epidemiology, vol. 60, no. 7, 2007, pp. 670-679.
19. S.B. Detmar et al., "How Are You Feeling? Who Wants to Know? Patients' and Oncologists' Preferences for Discussing Health-Related Quality-of-Life Issues," J. Clinical Oncology, no. 18, 2000, pp. 3295-3301.
20. B.J. Davison et al., "Information and Decision-Making Preferences of Men with Prostate Cancer," Oncology Nursing Forum, vol. 22, no. 9, pp. 1401-1408.
21. S.B. Detmar et al., "The Patient-Physician Relationship, Patient-Physician Communication during Outpatient Palliative Treatment Visits: An Observational Study, J. Am Medical Assoc., vol. 285, no. 10, 2001, pp. 1351-1357.
22. J. Greenhalgh, A.F. Long, and R. Flynn, "The Use of Patient Reported Outcome Measures in Routine Clinical Practice: Lack of Impact or Lack of Theory?" Social Science & Medicine, vol. 60, no. 4, 2005, pp. 833-843.
23. J. Greenhalgh and K. Meadows, "The Effectiveness of the Use of Patient-Based Measures of Health in Routine Practice in Improving the Process and Outcomes of Patient Care: A Literature Review," J. Evaluation in Clinical Practice, vol. 5, no. 4, 1999, pp. 401-416.
24. L. Baum et al., "A Maximization Technique Occurring in the Statistical Analysis of Probabilistic Functions of Markov Chains," Ann. Math. Statistics, vol. 41, no. 1, 1970, pp. 164-171.
25. P. Kalata et al., "German Rectal Cancer Study Group: Differences between Clinical Trial Participants and Patients in a Population-Based Registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry," Diseases of the Colon & Rectum, vol. 52, no. 3, pp. 425-437.
6 ms
(Ver 2.0)

Marketing Automation Platform Marketing Automation Tool